Regeneron, Sanofi shut down part of arthritis drug study after trial shows benefit for only sickest coronavirus patients

The drug, Kevzara, inhibits a pathway thought to contribute to the lung inflammation in patients with the most severe forms of Covid-19.

from Health and Science https://ift.tt/2Y8u7Lt
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH